Updates in Urologic Oncology


Updates in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Matthew Zibelman, MD, Associate Professor, Department of Hematology/Oncology and Director of Clinical and Translational Research for the GU Service Line at Fox Chase Cancer Center discusses the latest optimal therapies and strategies for managing mCRPC.
Matthew Zibelman, MD

Matthew Zibelman, MD

Assistant Professor, Department of Hematology/Oncology

Comprehensive Urology Care for Advanced Practice Providers:
Mastering Inpatient and Outpatient Management

Date: Thursday, June 11, 2026 | 7:30 PM - 4:00 PM, Friday, June 12, 2026 | 7:30 AM - 5:00 PM


Defeating Cancer Means Never Resting on Our Laurels

At Fox Chase Cancer Center, our faculty, fellows, and residents always look to the future to develop and collaborate on therapeutic breakthroughs to enhance life and extend it—never resting on accolades earned in the past.

Researchers Find Ancestry Impacts Effectiveness of Prostate Cancer Drugs

Camille Ragin, PhD, MPH, a professor in the Cancer Prevention and Control Research Program and Associate Director for Cancer Disparities Research and Research Integration at Fox Chase Cancer Center

Preparing for the Routine and Unforeseen in the Urologic OR

From 11 am to 11 pm, Joon Park, MSHI, BSN, RN, CNOR, Fox Chase Cancer Center Perioperative Evening Charge Nurse, manages the surgical staff workflow and patient assignments for the Fox Chase Cancer operating room.